Second Phase 3 Study of MDMA-assisted Therapy Reports Positive Results, Paving Way for New Drug Application Post published:September 14, 2023 Post category:News
Psychedelic Research Bulletin: July and August 2023 Post published:September 9, 2023 Post category:News/Psychedelics Research Review
California Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments Post published:September 1, 2023 Post category:News
BREAKING: Big Pharma Company Otsuka to Acquire Mindset Pharma for CAD $80m Post published:August 31, 2023 Post category:News
Cybin Set to Acquire British DMT Drug Developer Small Pharma Post published:August 28, 2023 Post category:News
Psychedelic Research Bulletin: June 2023 Post published:July 10, 2023 Post category:News/Psychedelics Research Review
Psychedelic Research Bulletin: May 2023 Post published:June 29, 2023 Post category:News/Psychedelics Research Review
State of Kentucky Sets aside $42 Million for Psychedelic Research, with Focus on Ibogaine Post published:May 31, 2023 Post category:News
MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD Post published:November 17, 2022 Post category:News/Press Release
BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics Post published:August 1, 2022 Post category:News